Number | Ticker | Country | Founded | IPO Year | Price | Revenue | Analyst Decision | Analyst Count |
---|---|---|---|---|---|---|---|---|
1 | IQiQIYI Inc. | China | 2009 | 2018 | $2.00 | $4,322,230,944.00 | Buy | 6 |
2 | ANGIAngi Inc. | United States | 2017 | 2017 | $1.85 | $1,217,676,000.00 | Buy | 9 |
3 | TVGrupo Televisa S.A. | Mexico | 1969 | 1993 | $1.81 | $3,622,556,115.00 | Buy | 4 |
4 | ERASErasca Inc. | United States | 2018 | 2021 | $1.99 | $0.00 | Strong Buy | 5 |
5 | SGMOSangamo Therapeutics Inc. | United States | 1995 | 2000 | $1.19 | $52,291,000.00 | Buy | 6 |
6 | VZLAVizsla Silver Corp. | Canada | 2017 | N/A | $2.00 | $0.00 | Strong Buy | 4 |
7 | PACBPacific Biosciences of California Inc. | United States | 2000 | 2010 | $1.65 | $173,147,000.00 | Buy | 13 |
8 | ALLOAllogene Therapeutics Inc. | United States | 2017 | 2018 | $1.88 | $43,000.00 | Strong Buy | 10 |
9 | PGENPrecigen Inc. | United States | 1998 | N/A | $1.34 | $3,963,000.00 | Buy | 5 |
10 | DADADada Nexus Limited | China | 2014 | 2020 | $1.36 | $1,423,236,152.00 | Buy | 6 |
11 | NKTRNektar Therapeutics | United States | 1990 | 1994 | $0.89 | $93,137,000.00 | Strong Buy | 5 |
12 | ATAIATAI Life Sciences N.V. | Germany | 2018 | 2021 | $1.51 | $331,000.00 | Strong Buy | 4 |
13 | PROKProKidney Corp. | United States | 2015 | N/A | $1.70 | $0.00 | Buy | 5 |
14 | GROYGold Royalty Corp. | Canada | 2020 | 2021 | $1.21 | $7,764,000.00 | Strong Buy | 4 |
15 | ALECAlector Inc. | United States | 2013 | 2019 | $1.81 | $61,508,000.00 | Buy | 6 |
16 | NOTEFiscalNote Holdings Inc. | United States | 2013 | N/A | $1.45 | $125,062,000.00 | Strong Buy | 6 |
17 | VORVor Biopharma Inc. | United States | 2015 | 2021 | $1.53 | $0.00 | Strong Buy | 7 |
18 | MCRBSeres Therapeutics Inc. | United States | 2010 | 2015 | $0.89 | $126,325,000.00 | Buy | 4 |
19 | LCTXLineage Cell Therapeutics Inc. | United States | 1990 | N/A | $0.63 | $8,719,000.00 | Strong Buy | 5 |
20 | INVZInnoviz Technologies Ltd. Ordinary shares | Israel | 2016 | N/A | $1.79 | $33,158,000.00 | Buy | 6 |
21 | VERUVeru Inc. | United States | 1971 | 1990 | $1.30 | $16,886,419.00 | Strong Buy | 4 |
22 | PYXSPyxis Oncology Inc. | United States | 2018 | 2021 | $1.64 | $16,146,000.00 | Strong Buy | 8 |
23 | EDITEditas Medicine Inc. | United States | 2013 | 2016 | $1.41 | $61,759,000.00 | Buy | 14 |
24 | KPTIKaryopharm Therapeutics Inc. | United States | 2008 | 2013 | $0.69 | $148,442,000.00 | Strong Buy | 4 |
25 | PRPLPurple Innovation Inc. | United States | 2010 | N/A | $1.20 | $504,838,000.00 | Buy | 4 |
26 | RVPHReviva Pharmaceuticals Holdings Inc. | United States | 2006 | N/A | $1.89 | $0.00 | Strong Buy | 5 |
27 | IMUXImmunic Inc. | United States | 2016 | N/A | $0.99 | $0.00 | Strong Buy | 6 |
28 | KOPNKopin Corporation | United States | 1984 | 1992 | $1.86 | $44,266,305.00 | Strong Buy | 4 |
29 | CTMXCytomX Therapeutics Inc. | United States | 2008 | 2015 | $0.87 | $126,617,000.00 | Buy | 6 |
30 | ASRTAssertio Holdings Inc. | United States | 1995 | 1997 | $0.81 | $125,763,000.00 | Strong Buy | 4 |
31 | ALXOALX Oncology Holdings Inc. | United States | 2015 | 2020 | $1.63 | $0.00 | Buy | 6 |
32 | ACETAdicet Bio Inc. | United States | 1947 | N/A | $0.94 | $0.00 | Strong Buy | 4 |
33 | CLSDClearside Biomedical Inc. | United States | 2011 | 2016 | $0.93 | $7,703,000.00 | Strong Buy | 6 |
34 | UNCYUnicycive Therapeutics Inc. | United States | 2016 | 2021 | $0.63 | $0.00 | Strong Buy | 4 |
35 | ATNMActinium Pharmaceuticals Inc. (Delaware) | United States | 2000 | N/A | $1.34 | $81,000.00 | Strong Buy | 4 |
36 | SPROSpero Therapeutics Inc. | United States | 2013 | 2017 | $0.87 | $106,455,000.00 | Buy | 4 |
37 | RLYBRallybio Corporation | United States | 2018 | 2021 | $0.88 | $598,000.00 | Buy | 6 |
38 | RANIRani Therapeutics Holdings Inc. | United States | 2012 | 2021 | $1.48 | $0.00 | Strong Buy | 5 |
39 | MRNSMarinus Pharmaceuticals Inc. | United States | 2003 | 2014 | $0.54 | $31,466,000.00 | Buy | 12 |
40 | FLUXFlux Power Holdings Inc. | United States | N/A | N/A | $1.87 | $63,850,000.00 | Strong Buy | 4 |
41 | XAIRBeyond Air Inc. | United States | 2011 | N/A | $0.42 | $2,342,000.00 | Strong Buy | 4 |
42 | ATHAAthira Pharma Inc. | United States | 2011 | 2020 | $0.55 | $0.00 | Buy | 4 |
43 | BTAIBioXcel Therapeutics Inc. | United States | 2017 | 2018 | $0.38 | $2,276,000.00 | Buy | 4 |
44 | AFMDAffimed N.V. | Germany | 2000 | 2014 | $1.11 | $6,287,085.00 | Strong Buy | 5 |
45 | CGTXCognition Therapeutics Inc. | United States | 2007 | 2021 | $0.79 | $0.00 | Strong Buy | 6 |
46 | LYRALyra Therapeutics Inc. | United States | 2005 | 2020 | $0.19 | $1,471,000.00 | Buy | 5 |
47 | PETWag! Group Co. | United States | 2015 | N/A | $0.26 | $76,747,000.00 | Strong Buy | 5 |
The FinQuota filters have identified what they believe to be the "Best Uptrend Penny Stocks To Buy in January 24, 2025" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.